Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells |
Park, Jae-Hyun
(Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea)
Ryu, Chung Heon (Department of Biomedical Science, College of Medicine, The Catholic University of Korea) Kim, Mi Jin (Department of Biomedical Science, College of Medicine, The Catholic University of Korea) Jeun, Sin-Soo (Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea) |
1 | Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB : Evaluation of a tetrazolium-based semiautomated colorimetric assay : assessment of chemosensitivity testing. Cancer Res 47 : 936-942, 1987 |
2 | Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, et al. : Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells 31 : 146-155, 2013 DOI |
3 | Jin HT, Youn JI, Kim HJ, Lee JB, Ha SJ, Koh JS, et al. : Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor. Hum Gene Ther 16 : 328-338, 2005 DOI |
4 | Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, et al. : Improving prognosis of glioblastoma in the 21st century : who has benefited most? Cancer 118 : 4228-4234, 2012 DOI |
5 | Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, et al. : Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65 : 3307-3318, 2005 DOI |
6 | Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, et al. : IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65 : 7573-7579, 2005 DOI |
7 | Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, et al. : A combination of IFN-beta and temozolomide in human glioma xenograft models : implication of p53-mediated MGMT downregulation. Cancer Chemother Pharmacol 61 : 653-659, 2008 DOI |
8 | Ryu CH, Yoon WS, Park KY, Kim SM, Lim JY, Woo JS, et al. : Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells. J Biomed Biotechnol 2012 : 987495, 2012 |
9 | Wakabayashi T, Kayama T, Nishikawa R, Takahashi H, Yoshimine T, Hashimoto N, et al. : A multicenter phase I trial of interferon-beta and temozolomide combination therapy for high-grade gliomas (INTEGRA Study). Jpn J Clin Oncol 38 : 715-718, 2008 DOI |
10 | Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, et al. : Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 68 : 9614-9623, 2008 DOI |
11 | Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 : 987-996, 2005 DOI |